Pemetrexed disodium
CAS : 357166-29-1
Ref. 3D-HPA16629
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Pemetrexed disodium
Synonymes :
- Alimta
- Pemetrexed disodium hepthydrate
- Pemetrexed disodium heptahydrate
Description :
Pemetrexed disodium is a drug that belongs to the group p2 of compounds. It is used in the treatment of colorectal cancer and other solid tumours such as lung, breast, stomach, and prostate cancers. Pemetrexed disodium is a prodrug which undergoes activation by hydrolysis to pemetrexed. Pemetrexed disodium has been shown to inhibit the production of thymidylate, which is an essential component for DNA synthesis. The minimal toxicity of this drug is due to its low reactivity with plasma proteins and lack of enzyme induction. Pemetrexed disodium has been shown to cause mitochondrial membrane potential loss in cells treated with radiation therapy. This loss activates apoptosis-inducing factor (AIF) and caspase-mediated cell death pathways.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
597.48 g/mol
Formule :
C20H19N5Na2O6·7H2O
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
